ArticleBrain sciences2022

Safety of Fingolimod in Patients with Multiple Sclerosis Switched from Natalizumab: Results from TRANSITION-A 2-Year, Multicenter, Observational, Cohort Study.

Helmut Butzkueven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.